Key Financial Data Of Reporting Company

SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. - Filing #7541066

Concept As at
2023-09-30
2023-07-01 to
2023-09-30
2023-04-01 to
2023-09-30
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-09-30
2022-07-01 to
2022-09-30
2022-04-01 to
2022-09-30
Key financial data of reporting company
Business results of reporting company
Net sales
11,884,047,000 JPY
25,090,903,000 JPY
10,348,731,000 JPY
Ordinary profit (loss)
3,756,455,000 JPY
9,194,133,000 JPY
5,928,734,000 JPY
Net assets
31,722,307,000 JPY
26,359,021,000 JPY
25,026,378,000 JPY
Total assets
68,558,336,000 JPY
57,242,205,000 JPY
56,896,815,000 JPY
Basic earnings (loss) per share
38.26
71.24
145.56
59.46
106.16
Diluted earnings per share
Equity-to-asset ratio
0.461 xbrli:pure
0.458 xbrli:pure
0.437 xbrli:pure
Net cash provided by (used in) operating activities
687,931,000 JPY
4,004,019,000 JPY
2,792,106,000 JPY
Net cash provided by (used in) investing activities
-3,671,934,000 JPY
-5,930,578,000 JPY
-2,579,651,000 JPY
Net cash provided by (used in) financing activities
2,124,234,000 JPY
6,266,243,000 JPY
6,270,035,000 JPY
Cash and cash equivalents
9,225,685,000 JPY
9,197,694,000 JPY
11,798,102,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.